Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT: FF)

Market Cap	203.20M
Revenue (ttm)	251.82M
Net Income (ttm)	-3.61M
Shares Out	24.48M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	21.80
Dividend	0.12 (1.46%)
Ex-Dividend Date	Jun 3, 2024

Volume	662
Open	8.14
Previous Close	8.24
Day's Range	8.14 - 8.34
52-Week Range	7.52 - 9.62
Beta	0.68
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 20, 2024

About FF

Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of drugs, food supplements, and other nutraceutical products and medical devices for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders, soluble, effervescent and chewable granules, filmed and effervescent tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatine capsules in various types of packaging, such as sachets, sticks, pillboxes, jars, blisters, tubes, and strips for v...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1984
• Employees: 753
• Stock Exchange: Borsa Italiana
• Ticker Symbol: FF

Financial Performance

In 2023, SERI's revenue was 184.76 million, an increase of 1.37% compared to the previous year's 182.25 million. Losses were -11.97 million, 173.0% more than in 2022.